IL-27 Human Recombinant produced in HEK cells is a glycosylated non-covalently heterodimer that consists of 2 chains, IL27A (IL27p28) having a Mw of 25kDa and IL27B (EBI3) having a Mw of 30kDa. Each chain migrates separately on SDS-PAGE.
The IL-27 protein is purified by proprietary chromatographic techniques
Recombinant human IL-27 is a glycosylated heterodimer produced in HEK cells. It comprises two polypeptide chains: IL27A (IL27p28) with a molecular weight of 25 kDa and IL27B (EBI3) with a molecular weight of 30 kDa. These chains separate during SDS-PAGE analysis.
The purification of IL-27 protein is achieved through specialized chromatographic methods.
IL-27 plays a crucial role in the regulation of the immune response. It has both pro-inflammatory and anti-inflammatory properties, making it a versatile cytokine in immune modulation. Some of its key functions include:
Recombinant human IL-27 is a synthetic form of the cytokine produced using recombinant DNA technology. It is optimized for use in various research applications, including cell culture, differentiation studies, and functional assays . The recombinant protein is typically produced in HEK293 cells and is available in research-grade quality, with high purity and low endotoxin levels .
Recombinant IL-27 is widely used in scientific research due to its diverse biological activities. Some of the key research areas include: